|
1
|
Onyoh EF, Hsu WF, Chang LC, Lee YC, Wu MS
and Chiu HM: The rise of colorectal cancer in Asia: Epidemiology,
screening, and management. Curr Gastroenterol Rep. 21:362019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akimoto N, Ugai T, Zhong R, Hamada T,
Fujiyoshi K, Giannakis M, Wu K, Cao Y, Ng K and Ogino S: Rising
incidence of early-onset colorectal cancer-a call to action. Nat
Rev Clin Oncol. 18:230–243. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moore MA, Sobue T, Kuriki K, Tajima K,
Tokudome S and Kono S: Comparison of Japanese, American-Whites and
African-Americans-pointers to risk factors to underlying
distribution of tumours in the colorectum. Asian Pac J Cancer Prev.
6:412–419. 2005.PubMed/NCBI
|
|
4
|
Hashiguchi Y, Muro K, Saito Y, Ito Y,
Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M,
et al: Japanese society for cancer of the colon and rectum.
Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2019 for the treatment of colorectal cancer. Int J Clin
Oncol. 25:1–42. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goodall GJ and Wickramasinghe VO: RNA in
cancer. Nat Rev Cancer. 21:22–36. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abe S, Matsuzaki J, Sudo K, Oda I, Katai
H, Kato K, Takizawa S, Sakamoto H, Takeshita F, Niida S, et al: A
novel combination of serum microRNAs for the detection of early
gastric cancer. Gastric Cancer. 24:835–843. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka
Y, Takahashi K, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Sonoda
T, et al: Integrated extracellular microRNA profiling for ovarian
cancer screening. Nat Commun. 9:43192018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimomura A, Shiino S, Kawauchi J,
Takizawa S, Sakamoto H, Matsuzaki J, Ono M, Takeshita F, Niida S,
Shimizu C, et al: Novel combination of serum microRNA for detecting
breast cancer in the early stage. Cancer Sci. 107:326–334. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamada A, Horimatsu T, Okugawa Y, Nishida
N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, et al: Serum
miR-21-5p, miR-29a, and miR-125b are promising biomarkers for the
early detection of colorectal neoplasia. Clin Cancer Res.
21:4234–4242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum
miR-21-5p as a diagnostic and prognostic biomarker in colorectal
cancer. J Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toiyama Y, Okugawa Y, Fleshman J, Boland
CR and Goel A: MicroRNAs as potential liquid biopsy biomarkers in
colorectal cancer: A systematic review. Biochim Biophys Acta Rev
Cancer. 1870:274–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takeuchi K, Naito M, Kawai S, et al: Study
profile of the Japan multi-institutional collaborative cohort
(J-MICC) study. J Epidemiol. 31:660–668. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to the ionizing
radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Asai Y, Naito M, Suzuki M, Tomoda A,
Kuwabara M, Fukada Y, Okamoto A, Oishi S, Ikeda K, Nakamura T, et
al: Baseline data of Shizuoka area in the Japan multi-institutional
collaborative cohort study (J-MICC Study). Nagoya J Med Sci.
71:137–144. 2009.PubMed/NCBI
|
|
15
|
Morita E, Hamajima N, Hishida A, Aoyama K,
Okada R, Kawai S, Tomita K, Kuriki S, Tamura T, Naito M, et al:
Study profile on baseline survey of Daiko Study in the Japan
multi-institutional collaborative cohort study (J-MICC Study).
Nagoya J Med Sci. 73:187–195. 2011.PubMed/NCBI
|
|
16
|
Schwarzenbach H, da Silva AM, Calin G and
Pantel K: Data normalization strategies for MicroRNA
quantification. Clin Chem. 61:1333–1342. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie B, Ding Q, Han H and Wu D: miRCancer:
A microRNA-cancer association database constructed by text mining
on literature. Bioinformatics. 29:638–644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Storey JD: The positive false discovery
rate: A Bayesian interpretation and the q-value. Ann. Statist.
31:2013–2035. 2003. View Article : Google Scholar
|
|
19
|
Coronel-Hernández J, López-Urrutia E,
Contreras-Romero C, Delgado-Waldo I, Figueroa-González G,
Campos-Parra AD, Salgado-García R, Martínez-Gutierrez A,
Rodríguez-Morales M, Jacobo-Herrera N, et al: Cell migration and
proliferation are regulated by miR-26a-5p in colorectal cancer via
the PTEN-AKT axis. Cancer Cell Int. 19:802019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
López-Urrutia E, Coronel-Hernández J,
García-Castillo V, Contreras-Romero C, Martínez-Gutierrez A,
Estrada-Galicia D, Terrazas LI, López-Camarillo C,
Maldonado-Martínez H, Jacobo-Herrera N and Pérez-Plasencia C:
MiR-26a downregulates retinoblastoma in colorectal cancer. Tumour
Biol. Apr 26–2017.(Epub ahead of print). doi:
10.1177/1010428317695945. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chai B, Guo Y, Cui X, Liu J, Suo Y, Dou Z
and Li N: MiR-223-3p promotes the proliferation, invasion and
migration of colon cancer cells by negative regulating PRDM1. Am J
Transl Res. 11:4516–4523. 2019.PubMed/NCBI
|
|
22
|
Okugawa Y, Yao L, Toiyama Y, Yamamoto A,
Shigemori T, Yin C, Omura Y, Ide S, Kitajima T, Shimura T, et al:
Prognostic impact of sarcopenia and its correlation with
circulating miR-21 in colorectal cancer patients. Oncol Rep.
39:1555–1564. 2018.PubMed/NCBI
|
|
23
|
Suzuki HI, Young RA and Sharp PA:
Super-enhancer-mediated RNA processing revealed by integrative
MicroRNA network analysis. Cell. 168:1000–1014.e15. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Asakura K, Kadota T, Matsuzaki J, Yoshida
Y, Yamamoto Y, Nakagawa K, Takizawa S, Aoki Y, Nakamura E, Miura J,
et al: A miRNA-based diagnostic model predicts resectable lung
cancer in humans with high accuracy. Commun Biol. 3:1342020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamada H, Suzuki K, Fujii R, Kawado M,
Hashimoto S, Watanabe Y, Iso H, Fujino Y, Wakai K and Tamakoshi A:
Circulating miR-21-5p, miR-29a, and miR-126 are associated with
premature death risk due to cancer and cardiovascular disease: The
JACC study. Sci Rep. 11:52982021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balzano F, Deiana M, Giudici SD, Oggiano
A, Baralla A, Pasella S, Mannu A, Pescatori M, Porcu B, Fanciulli
G, et al: miRNA stability in frozen plasma samples. Molecules.
20:19030–19040. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang K, Yuan Y, Cho JH, McClarty S, Baxter
D and Galas DJ: Comparing the MicroRNA spectrum between serum and
plasma. PLoS One. 7:e415612012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barrera-Ramirez J, Lavoie JR, Maganti HB,
Stanford WL, Ito C, Sabloff M, Brand M, Rosu-Myles M, Le Y, Allan
DS, et al: Micro-RNA profiling of exosomes from marrow-derived
mesenchymal stromal cells in patients with acute myeloid leukemia:
Implications in leukemogenesis. Stem Cell Rev Rep. 13:817–825.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang H, Hu Z and Chen L: Enhanced plasma
miR-26a-5p promotes the progression of bladder cancer via targeting
PTEN. Oncol Lett. 16:4223–4228. 2018.PubMed/NCBI
|
|
30
|
Miyamoto K, Seki N, Matsushita R, Yonemori
M, Yoshino H, Nakagawa M and Enokida H: Tumour-suppressive
miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by
regulating PLOD2 in bladder cancer. Br J Cancer. 115:354–363. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye MF, Lin D, Li WJ, Xu HP and Zhang J:
MiR-26a-5p serves as an oncogenic MicroRNA in non-small cell lung
cancer by targeting FAF1. Cancer Manag Res. 12:7131–7142. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang ZM, Ge HF, Yang CC, Cai Y, Chen Z,
Tian WZ and Tao JL: MicroRNA-26a-5p inhibits breast cancer cell
growth by suppressing RNF6 expression. Kaohsiung J Med Sci.
35:467–473. 2019.PubMed/NCBI
|
